OCD – Mental health issues vs A conservative society


Uday Deb

Growing up, I had a habit where I would check whether my house’s door was closed countless times, even after closing the door. Another habit I had was when I had to keep checking if I had kept certain things in the right place even after keeping them in place. My habits were tiring and exhausted my nervous system. After years of exhaustion, I finally met a psychologist and was told that the habits were patterns of a disorder known as OCD.

According to the American Psychiatric Association, OCD, which stands for Obsessive-compulsive disorder, is a disorder where people live with recurring, unwanted thoughts, ideas, or sensations, which drive them to a compulsive obsession of carrying out tasks repeatedly. These include behaviors such as hand washing, checking the position of things, cleaning, etc.

According to ocduk.org, the disease is so debilitating and disabling that the World Health Organisation ranks the disorder in the top 10 of the most disabling illnesses of any sort. The impact of OCD on people’s lives is intense. In cases when the condition becomes extremely severe, the Better Health channel reports that people will tend to avoid anything and everything that will trigger their fears of obsession.

This avoidance spans towards daily activities such as eating, drinking, reading, or even walking. This avoidance can lead to people being unable to carry out day to day tasks and cause house boundedness.  Critically, these harmful implications of OCD in peoples’ lives often lead to cases of depression and other anxiety disorders.  As a result, patients’ struggles should not be underestimated, and they should receive support from society. Critically, with the right support from society, patients should ensure that they receive appropriate help from medical professionals.

Like all mental health illnesses worldwide, OCD is no different when it comes to seeing societies neglect the well-being of patients suffering from the disorder. In some conservative societies worldwide (notably India), mental health issues such as OCD, Depression, or even Anxiety are either misunderstood or unrecognized or even classified as underrated.

The case of mental health issues being classified as underrated in India arises due to people’s concerns about their social status or standing. People believe that revealing their mental health issues reveal their vulnerabilities, as they wrongly fear that it exposes their weaknesses to other people in society. On the other hand in this case, society is also wrong as it judges these people based on their vulnerabilities, which are in turn natural feelings of any human being and wrongly framed as weaknesses.

Consequently, due to the flawed conservative ideologies concerning mental health, patients are inappropriately characterized as crazy or weak people in society. People with these conservative beliefs tend to stay unaware and suffer in silence by hiding their pain or suppressing the pain of their loved ones who may be suffering as well. As a result, this unnecessary conservative ego stops people or their family members from not just accepting their pain, i.e., opening up about their struggles, but also from seeking help from professionals.

Critically, with an increasing amount of people suffering from mental health issues such as  OCD, Depression, Anxiety, or even ADHD,  it’s time for Indian societies to liberalize their mental health ideologies. Professionals in the field of mental health should work towards change by increasing awareness about the perils of mental health illnesses such as OCD or even Depression on the human body.

They should provide consequential exposure on social media and insight through news publications, host knowledgeable seminars and webinars on different platforms. Most importantly, Doctors should influentially break the stigmatic iceberg of calling mental health suffers crazy through word of mouth about its consequences in society.

Over the years, if a change in mental health liberalization is successfully facilitated as a result of the increased exposure by mental health professionals in societies, people will feel psychologically liberated. Sufferers will feel safe when facing their vulnerabilities – openly talking about psychological distress, and will find it easier to receive solutions to their struggles through the resources of ever-advancing medicine. Sufferers with new liberal ideologies will then not be worried about their social status or weaknesses and will be irrevocably treated or seen by others in society with normality. Societies will be healthier, and the word crazy will go into obsolescence.

Top Comment



2 days ago

We felt very happy and proud to see our son appear on Ms Tanvi Shuklaâ s programme on Mental health issues this evening.


Views expressed above are the author’s own.



Views expressed above are the author’s own.


Real Event OCD: Symptoms, Treatments, and More

Obsessive-compulsive disorder (OCD) is a condition that is characterized by a cycle of recurring and intrusive thoughts and behaviors. These thoughts, or obsessions, can lead to uncontrollable behaviors, or compulsions.

In the mind of a person with this mental health condition, the compulsions should help alleviate the obsessions. However, they rarely do.

Instead, the person performs the compulsions over and over again without resolution. The thoughts and compulsions can interfere with the person’s ability to:

  • perform daily tasks
  • hold a job
  • leave their home

In most cases, these intrusive thoughts are worries or anxieties about things that might happen. You might leave the oven on and start a fire.

Sometimes, however, these obsessions may come from thinking about something that already happened. This type of OCD is called real event OCD.

According to the Anxiety and Depression Association of America, real event OCD is not a unique diagnosis. It is OCD that develops when responding to actual events.

Real event OCD occurs when you have obsessive thoughts about an event that occurred in your life. This obsession-compulsion cycle of real event OCD may look a bit different from other types.

Primarily, the compulsion is an inability to stop thinking about the event. You play it over and over again in your mind, seeking answers that you cannot find.

But like other forms of OCD, real event OCD can often be treated if it is recognized and addressed. Keep reading to learn the symptoms of real event OCD and who can help treat it.

Electrical Brain Stimulation May Alleviate Obsessive-Compulsive Behaviors

Obsessive-compulsive disorder (OCD) is marked by repetitive, anxiety-inducing thoughts, urges and compulsions, such as excessive cleaning, counting and checking. These behaviors are also prevalent in the general population: one study in a large sample of U.S. adults found more than a quarter had experienced obsessions or compulsions at some point in their life. Although most of these individuals do not develop full-blown OCD, such symptoms can still interfere with daily life. A new study, published on January 18 in Nature Medicine, hints that these behaviors may be alleviated by stimulating the brain with an electrical current—without the need to insert electrodes under the skull.

Robert Reinhart, a neuroscientist at Boston University, and his group drew on two parallel lines of research for this study. First, evidence suggests that obsessive-compulsive behaviors may arise as a result of overlearning habits—leading to their excessive repetition—and abnormalities in brain circuits involved in learning from rewards. Separately, studies point to the importance of high-frequency rhythms in the so-called high-beta/low-gamma range (also referred to as simply beta-gamma) in decision-making and learning from positive feedback.

Drawing on these prior observations, Shrey Grover, a doctoral student in Reinhart’s lab, hypothesized with others in the team that manipulating beta-gamma rhythms in the orbitofrontal cortex (OFC)—a key region in the reward network located in the front of the brain—might disrupt the ability to repetitively pursue rewarding choices. In doing so, the researchers thought, the intervention could reduce obsessive-compulsive behaviors associated with maladaptive habits.

To test this hypothesis, Grover and his colleagues carried out a two-part study. The first segment was aimed at identifying whether the high-frequency brain activity influenced how well people were able to learn from rewards. The team recruited 60 volunteers and first used electroencephalography to pinpoint the unique frequencies of beta-gamma rhythms in the OFC that were active in a given individual while that person took part in a task that involved associating symbols with monetary wins or losses. Previous work had shown that applying stimulation based on the particular patterns of rhythms in a person’s brain may enhance the effectiveness of the procedure.

The participants were then split into three groups, all of whom received a noninvasive form of brain stimulation known as transcranial alternating current stimulation (tACS), which was applied to the OFC for 30 minutes over five consecutive days. Each group had a different type of stimulation: One received personalized currents tuned to an individual’s beta-gamma frequencies. Another was exposed to an “active” placebo, consisting of stimulations at a lower frequency. And the third was a “passive” placebo group in which no significant current was applied to the brain. Those who received the personalized beta-gamma stimulation became less able to make optimal choices on the reward-based learning tasks—changes not observed in the two placebo groups.

Further assessment of the participants’ behavior using computational models of reward-based learning suggested that the personalized tACS disrupted the learning process by making people more likely to try out different options rather than sticking with only one—even if they were less likely to result in a reward.

These findings set the stage for the second part of the study, in which the team set out to examine whether manipulating the beta-gamma rhythms typically engaged during reward-based learning would influence obsessive-compulsive behaviors. The researchers carried out a similar set of experiments on another set of volunteers: 64 people who did not have a formal OCD diagnosis but who exhibited symptoms such as checking, hoarding and obsessing. Participants received either personalized beta-gamma stimulation or an active placebo. Those in the personalized beta-gamma group experienced a reduction in compulsive behaviors that persisted for up to three months. And those with more of those obsessive-compulsive characteristics prior to stimulation exhibited the biggest changes.

According to Grover, the team decided to study people with symptoms of OCD but no diagnosis of the disorder because researchers have increasingly been viewing obsessive-compulsive behaviors on a mild-to-severe spectrum. And even in the absence of clinically diagnosed OCD, such symptoms can cause significant distress. “By examining a nonclinical population exhibiting a range of obsessive-compulsive behaviors, we were able to examine the effectiveness of [an intervention] that may be helpful to a larger pool of individuals,” Grover says. Yet the researchers’ findings also suggest “that if we were to extend such an intervention to individuals diagnosed with obsessive-compulsive disorder or to other conditions of compulsivity—gambling disorder, addiction, some forms of eating disorders—-we might be able to observe strong effects.”

The long-lasting effects on obsessive-compulsive behaviors is “quite impressive,” says Trevor Robbins, a professor of cognitive neuroscience at the University of Cambridge, who was not involved in this research. “[Neuromodulation] is certainly a treatment that should be investigated rigorously for conditions like OCD.”

Carolyn Rodriguez, a psychiatrist and neuroscientist at Stanford University, who was also not involved in the study, says that because it was carried out in a nonclinical population without a formal diagnosis, the implications of these findings remain to be seen. “The neurobiology of people who are nonclinical but have these kinds of behaviors may be different than individuals who are diagnosed with OCD,” she adds. “These findings are an interesting start, [but] we need to understand how it’s relevant to people who have OCD.” Rodriguez also points out that there are already several treatments available for the condition, including medication, therapy and a Food and Drug Administration–approved device that utilizes transcranial magnetic stimulation (TMS), a noninvasive method that uses magnetic fields to stimulate the brain. (Rodriguez is currently leading a clinical trial of TMS for OCD.)

The potential therapeutic effects of tACS on memory, food craving and other neural processes have been tested in dozens of studies in the past. Questions have been raised about whether this method actually exerts any meaningful changes in the brain, however. In the new study, what, exactly, the high-frequency tACS did to the brain remains unknown. But Grover notes that the researchers’ two placebo conditions—particularly the one that involves stimulating at a different frequency—provide strong evidence that the high-frequency stimulation was responsible for the behavioral effects the team observed.

Grover and his colleagues are currently working on further experiments to pinpoint the mechanisms underlying their intervention. And they hope to conduct studies with clinical populations diagnosed with OCD in the near future. “[The recent paper] is just a preliminary step toward further understanding why this high-frequency activity is so important for obsessive-compulsive behavior,” Grover says. “The fact that we can observe changes in these symptoms even now suggests there may actually be clinical benefit to this—and gives us all the more reason to try to extend the findings of this research.”

Hearing loss and anxiety: What’s the connection?

If you’ve just been diagnosed with hearing loss—or your hearing has gotten worse—you may be feeling anxious.

Anxiety is a persistent heightened state of alert. It’s a normal reaction to stressful situations, but for some people it spirals out of control and becomes a disorder in and of itself. Often, that means they can’t stop thinking “what if?” 

Hearing loss can trigger or feed into anxious thinking or other symptoms, though the links haven’t been thoroughly studied. Sometimes the anxiety and rumination isn’t strictly focused on hearing, but seeps out like a stain on a dress.

When you have hearing loss, you may worry about a lot of things: What if I don’t hear something important? What if I misunderstand someone and embarrass myself? What if my hearing aid batteries run out? What if I get passed up for a promotion because of my hearing loss? What if my tinnitus gets worse? And so on. 

Physical signs of anxiety

Anxiety can trigger physical symptoms: nausea, dizziness, muscle aches, insomnia and trouble concentrating, among others. You may feel a sense of dread or doom, as if you’re standing on the edge of windy cliff.

If these thoughts and physical sensations are becoming persistent, intrusive and affecting your quality of life, it may be time to seek professional help. This may require treating both your hearing loss and your anxiety. How this plays out day-to-day varies by your unique circumstances, however.

Why are you anxious? 

Mental health professionals generally categorize anxiety into five buckets: obsessive-compulsive disorder, post-traumatic stress disorder, social anxiety disorder, panic disorder and generalized anxiety disorder. If you have a car accident and banged your head, you might experience rapid hearing loss and possibly other symptoms of post-traumatic stress disorder. Your symptoms and treatment plan might look very different from someone who has slowly been losing her hearing and is constantly looking for signs that she’s developing dementia (when it’s really just hearing loss).

Complicating the picture is that people with hearing loss may have a related condition that causes tinnitus and dizziness, which can be unsettling and anxiety inducing, as well.

Related: Why anxiety often accompanies balance disorders, and what to do about it

What the research shows

Struggling in everyday situations that aren’t difficult for other people is stressful. Anxiety is one response to stress. In a 12-year study of nearly 4,000 French people age 65 and up, participants diagnosed with hearing loss at the beginning had a greater chance of developing anxiety symptoms over time.

Interestingly, people with vision loss weren’t more likely to become anxious. It’s often observed that people accept wearing glasses more easily than hearing aids—possibly because of the anxiety associated with hearing loss.  

In general, evidence of a tie is stronger when it corresponds with severity. In a study of more than 1,700 adults aged 76 to 85 who were not living in an institution, those with mild hearing loss had a 32 percent higher risk of reporting anxiety. If you had a moderate or higher loss, your chance of anxiety rose by 59 percent.

Hearing loss severity and tinnitus increase risk

The tie to severity also showed up in research among adults of all ages. In an overview of 25 studies that evaluated more than 17,000 adults in all, the team found a higher risk of anxiety if your hearing loss was more severe or if you had tinnitus.

None of this means that you’re doomed to be anxious because of your hearing loss. Within the overview, in five studies that looked at symptoms among the hearing impaired at one point in time, between 15 percent and 31 percent of the participants had clinically significant anxiety symptoms. In other words, most didn’t.

Those numbers are higher than we’d like—but anxiety is common. About 18 percent of American adults qualify as having an anxiety disorder in any year, the Anxiety and Depression Association of America (ADAA) reports.

Do I have social anxiety or am I just frustrated by not hearing?

Age-related hearing loss, called presbycusis, typically sneaks up on you over time. You may not even notice that you’re giving up on noisy social occasions because of your hearing loss. Instead, you accept that you “just don’t like parties.”

Loneliness can creep up on you as well, and contribute to medical problems and yes, anxiety.

People with social anxiety are afraid of any situation in which they might be negatively judged, from conversations with superiors on the job to dates, small-talk and parties.

Hearing loss does create situations that can irritate other people. When you can’t hear well, you may miss clues that let you know when someone is about to talk or hasn’t yet finished, and end up interrupting. You might pretend to hear, or guess, or think you heard someone—and reply inappropriately. You didn’t hear the joke—and you’re the only one who didn’t laugh. So hearing loss can make you feel left out or socially unskilled.

If you enjoy being around people, your social anxiety is mild. For example, Dr. Blazer notes that some people go to religious services, but come in late and leave early so they don’t have to chit-chat. Their problems might be solved by hearing aids. If you have extreme social anxiety, simply sitting with people would make you anxious.

People diagnosed with generalized anxiety disorder (GAD) may be flooded with worry and struggle with a gamut of physical symptoms for days before a date or job interview.

Communication tools can help

If your problem is primarily the struggles of socializing with hearing loss, you can learn to love social gatherings again. You can take someone to a quieter room and have a great conversation—once you’ve got your hearing aids. Also, learn the key communication tools for people with hearing impairments. 

Even with hearing aids, living with hearing loss requires an attitude adjustment. For example, you may need to accept that you can’t hear the people at the other end of a long table. (As a person with hearing loss, I’ve learned not to be embarrassed when other people are laughing at a joke I didn’t catch. I just say, “I didn’t hear that.”) 

Could anxiety disorders hurt your hearing?

Possibly. In a study of more than 10,500 adults in Taiwan, researchers found a greater risk of sudden hearing loss among those with an anxiety disorder. In the 12-year French study mentioned above, volunteers diagnosed with GAD but not hearing loss at the beginning of the research were more likely to develop hearing loss than those without GAD. Interestingly, those with GAD were not more likely to experience a decline in their vision.

More study would explain why hearing in particular might be affected by anxiety. 

Anxiety is ‘highly treatable’ 

What can you do? Most people with anxiety problems are never treated, the ADAA points out, although these disorders are “highly treatable.”

“Anxiety is very common but the healthcare profession doesn’t pay attention to it,” psychiatrist Dan Blazer told Healthy Hearing. Dr. Blazer, professor emeritus of psychiatry and behavioral sciences at Duke University Medical Center, chaired the National Academies Committee on Accessible and Affordable Hearing Health Care for Adults. “We just throw up our hands.”

So don’t wait for an annual checkup—you’ll need to reach out to your doctor or seek a psychiatrist or psychologist. Treatment for anxiety may include medication—Lexapro and Paxil are first-line choices—and talk-therapy such as cognitive behavioral therapy (CBT), in which you learn how to tame repetitive and negative thoughts. For the physical symptoms, tools like exercise and meditation can help. If you have tinnitus, you also may be grappling with anticipatory anxiety.

Hearing aids and other devices 

And of course, if hearing loss is triggering anxiety, hearing aids could dramatically improve your life. While they will not restore your hearing to normal, they can help you deal with some of the worrying aspects of hearing loss, such as communication snafus. There are also phone apps and other devices you can use to manage specific fears. For example, if you need to set an alarm very loud but wake up panicked by the shriek in the dark, consider a clock that produces a light like the sunrise, or a bed shaker alarm. There are many other assistive listening devices that can make hearing loss less anxiety-inducing.

But just the thought of hearing aids makes me anxious 

When you’re anxious in general or about hearing, you may be anxious about your hearing aids as well.

Although it’s common to stall and be anxious when you first face your hearing problem, people tend to adjust to hearing aids over weeks or months, retired audiologist Richard Carmen and psychiatrist Dr. Shelley Uram write. Men are especially likely to take pride in being healthy, so they resist admitting what seems like a weakness.

Some patients seem to adjust, largely to please other people, but months later, simply stop wearing their aids. “Because their anxiety was never confronted or because their anxiety is too overwhelming, their coping mechanisms are unable to rise to the occasion of dealing with the hearing loss or hearing aids,” Carmen and Uram note. When these people give up on their hearing aids, they end up feeling isolated. Too many dig in their heels and get angry at family and friends who complain that they can’t hear. 

Dr. Blazer describes a patient, a prominent man who felt uncomfortable attending his Lion’s Club because he couldn’t keep up with the conversation. “When he came to see me, five minutes in, he’d say, ‘I probably should put on my hearing aid,’” Dr. Blazer told Healthy Hearing.  

Don’t be that person. Instead, be open with your hearing care team so together you can make sure your hearing aids are rewarding enough to wear through the day. Don’t let anxiety get in the way.

Luke Combs Says He Has Anxiety and OCD

Luke Combs is speaking publicly about having anxiety and obsessive thoughts in a new installment of The Big Interview With Dan Rather.

Before the full episode airs on Wednesday (Jan. 13), fans can check out a clip of Combs detailing his mental health struggle.

“It’s something that I always struggled with, and always affected me,” the singer reveals. “The first time I can remember is probably middle school up to the end of college, and I still have my moments here and there.”

Combs says he lives with a lesser-known form of obsessive compulsive disorder (OCD) known as Purely Obsessional OCD, which is marked by intrusive, distressing thoughts that come in waves.

“Essentially, my version of messing with the blinds or straightening the carpet are thoughts that I play over and over in my head,” Combs continues. “[For example,] it’ll be something about my health. I’ll be worried that I’m … about to have a heart attack, or a stroke. It becomes this very obsessive thing that I, you literally can never have an answer to.”

Combs says the key to taking control of his anxiety has been in arming himself with knowledge and understanding the patterns behind these obsessive thoughts.

“You have to teach yourself to be comfortable with the fact that you will never get an answer, and that it is a super uncertain thing. That’s what I particularly have struggled with. Sometimes that’s tough, but it’s something that you learn about yourself,” he points out.

Though he still deals with anxiety from time to time, Combs says that for the most part, he feels in control of his OCD.

“It’s something that I’ve learned about, and I’ve been able to get a hold of. So it’s been great to [feel] free from those things, for a long time now,” he says.

The singer certainly hasn’t let his struggles stand in the way of a successful musical career. 2020 brought Combs another banner year of chart and streaming successes, and his sophomore album, What You See is What You Get, was the top-selling album of the year. He’s also responsible for two of the Top 10 most-played country songs of 2020, with “Lovin’ on You” and “Does to Me” (his duet with Eric Church) coming in at No. 9 and No. 8, respectively.

The Big Interview With Dan Rather airs on Wednesday (Jan. 13) at 8PM ET on AXS TV.

Luke Combs Says His OCD Causes Him to Fear He’s ‘About to Have a Heart Attack’

The country star, 30, appears in an upcoming episode of The Big Interview with Dan Rather, which will air on Wednesday at 8 p.m. EST on AXS TV. While discussing some of the positive progress he has made while coping with anxiety, Combs told the host, 89, “I still have my moments here and there. It’s something I’ve learned about and it’s something I’ve been able to get a hold of.”

Anxiety Disorders and Depression Treatment Market Share by Top Manufacturers – Eli Lilly and Company

Pune, Maharashtra, India, January 13 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Anxiety Disorders and Depression Treatment Market is valued at USD 16.83 Billion in 2018 and expected to reach USD 20.97 Billion by 2025 with the CAGR of 3.19% over the forecast period.

Rising mental health issues such as depression, anxiety disorders, schizophrenia and growing geriatric population are boosting the global market for anxiety disorders and depression treatment.

Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1241

Scope of the Report:

Conditions of depression and anxiety are the most prevalent psychological conditions affecting a large population across the globe. Depression is linked to an emotional state which further affects the individual concerned actions, thoughts and sometimes sleeping patterns. Depression is a brain related psychiatric condition which includes feeling depressed and exhausted, losing motivation and having trouble enjoying every day routine activities. Depression exists mainly because of causes like social isolation and stressful work climate. While anxiety is a natural response to stress that can be helpful in certain cases. Anxiety disorders and depression are distinct, but depressed people frequently experience anxiety disorder like symptoms such as nervousness, irritability, sleeping and concentration issues. Persons with anxiety feeling may interfere with everyday tasks such as job performance, school work and relationships. Anxiety disorders vary from natural feelings of nervousness or anxiety, which include extreme fear or anxiety. High anxiety rates contribute to anxiety disorders that include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic stress-based disorder. There are various effective treatments are available for moderate and severe depression and anxiety. Psychological treatments may be provided by health care providers such as behavioral activation, cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) or antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs). Specific psychological treatment methods like face-to-face psychological therapies are also provided.

The global anxiety disorders and depression treatment market is segmented on the basis of product, indication and region and country level. On the basis of product, the global anxiety disorders and depression treatment market are classified into drugs, therapy and devices. Based on indication, the anxiety disorders and depression treatment market is classified into major depressive disorder, obsessive- compulsive disorder, phobias and traumatic stress disease.

The regions covered in global anxiety disorders and depression treatment market reports are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, global market is sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Anxiety Disorders and Depression Treatment Companies:

Global anxiety disorders and depression treatment market reports cover prominent players,

Eli Lilly and Company Forest Laboratories, Inc. VistaGen Therapeutics AstraZeneca PLC Lundbeck A/S Sanofi-Aventis Merck Co., Inc. EverInsight Therapeutics Inc. Pfizer, Inc. GlaxoSmithKline plc Johnson Johnson Others

Global Anxiety Disorders and Depression Treatment Market Dynamics –

Rising mental health issues such as depression, anxiety disorders, schizophrenia is the key driver for anxiety disorders and depression treatment market. According to WHO, depression will affect around 264 million people of all ages worldwide in 2020. Depression at its worst can lead to suicide. Every year around 800,000 people die from suicide. According to World Health Organization (WHO), depression currently affects an estimated 350 million people worldwide. Depression affects men between 10 % – 15 % and women between 10 % – 25 %. According to an analysis from the National Center for Health Statistics  in 2017  the 16.6 % of people aged 40 to 59, 7.8 % of people those aged 20 to 39 and 3.4 % of teenagers aged 12 to 19 uses antidepressants drugs. Worldwide, the prevalence of anxiety disorders varies from 2.5 % to 7 % per country. An estimated 284 million people globally reported an anxiety disorder in 2017, making it the most common neurodevelopmental or mental health condition. Approximately 63 % which account nearly 179 million were female, compared to 105 million.

Another factor which drives the anxiety disorders and depression treatment market is growing geriatric population with higher mental illness rates. Incidences of anxiety disorders in the geriatric population are increasingly growing. This population is prone to psychological illnesses and thus contributes significantly to this market’s growth. According to an analysis from the National Center for Health Statistics in 2017 the percentage of older adults taking antidepressants over 60 years of age was 19.1%. The number of people aged 80 or older was around 125 million, according to WHO in 2018. Whereas, the WHO predicted that, between 2015 and 2050, the proportion of the world’s population over 60 years would nearly double from 12 to 22 %. Nonetheless, the poor pipeline of new products, patent expiration of existing antidepressant drugs and high costs associated with the usage of devices are existing factors that limit the global demand for anxiety disorders and treatment for depression. In addition, the advent of technologically advanced technologies such as experimental devices used to stimulate the brain and augmented reality perception technologies using smartphone-based software will create opportunities for anxiety disorders and depression treatment market over the forecast period.

Anxiety Disorders and Depression Treatment Market Regional Analysis –

In North America, the global anxiety disorders and depression treatment market is highly attractive due rise in anxiety disorder incidence rate, sedentary lifestyle and stressful work environments are the main factors responsible for rising cases of anxiety disorders. Depression affects around 1 in every 5 individuals in the US, according to CDC. It is estimated that in the United States around 16.2 million adults who accounts approximately 6.7 % of American adults, have experienced at least one major depressive disorder. Anxiety disorders are the most prevalent mental condition in the United States; people with age 18 and older in the United States affected by anxiety around 40 million which account 18.1 % of the population per year.

Anxiety Disorders and Depression Treatment Market Segmentation –

By Product: Drugs, Therapy, Devices

By Indication: Major Depressive Disorder, Obsessive- Compulsive Disorder, Phobias And Traumatic Stress Disease

Full Research Report @ https://brandessenceresearch.com/healthcare/anxiety-disorders-and-depression-treatment-market-size

Other Related Reports:


About us:

Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com

Website: https://brandessenceresearch.com/   

Article: https://businessstatsnews.com   

Blog: https://technologyindustrynews.com   

Blog: https://marketstatsreport.com   

Blog: https://industrywatchnews.com/

This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Obsessive-Compulsive Disorder (OCD)

Obsessive-compulsive disorder is a mental disorder whose main symptoms include obsessions and compulsions, driving the person to engage in unwanted, oftentimes distress behaviors or thoughts. It is treated through a combination of psychiatric medications and psychotherapy.

Obsessive-compulsive disorder (OCD) is an anxiety disorder characterized by recurrent and disturbing thoughts (called obsessions) and/or repetitive, ritualized behaviors that the person feels driven to perform (called compulsions). Obsessions can also take the form of intrusive images or unwanted impulses. The majority of people with OCD have both obsessions and compulsions, but a minority (about 20 percent) have obsessions alone or compulsions alone (about 10 percent).

The person with OCD usually tries to actively dismiss the obsessions or neutralize them by engaging in compulsions or avoiding situations that trigger them. In most cases, compulsions serve to alleviate anxiety. However, it is not uncommon for the compulsions themselves to cause anxiety — especially when they become very demanding.

A hallmark of OCD is that the person recognizes that their thoughts or behaviors are senseless or excessive.

However, the drive can be so powerful that the person caves in to the compulsion even though they know it makes no sense. One woman spent hours each evening sifting through the household trash to ensure that nothing valuable was being discarded. When asked what she was looking for, she nervously admitted, “I have no idea, I don’t own anything valuable.”

Some people who have had OCD for a long time may stop resisting their compulsive drives because they feel it’s just easier to give in to them.

Most OCD sufferers have multiple types of obsession and compulsion. Someone with OCD may complain primarily of obsessive-compulsive symptoms involving asbestos contamination, but a detailed interview may disclose that he/she silently counts floor tiles and hoards junk mail.

Learn more: Frequently Asked Questions and Do I Have OCD?

Examples of Obsessions

Common types of obsessions include concerns with contamination (e.g., fear of dirt, germs or illness), safety/harm (e.g., being responsible for a fire), unwanted acts of aggression (e.g., unwanted impulse to harm a loved one), unacceptable sexual or religious thoughts (e.g., sacrilegious images of Christ) and the need for symmetry or exactness.

Examples of Compulsions

Common compulsions include excessive cleaning (e.g., ritualized hand washing); checking, ordering, and arranging rituals; counting; repeating routine activities (e.g., going in/out of a doorway) and hoarding (e.g., collecting useless items). While most compulsions are observable behaviors (e.g., hand washing), some are performed as unobservable mental rituals (e.g., silent recitation of nonsense words to vanquish a horrific image).

Global Anxiety Disorders And Depression Treatment Market Size, Share, Trends, Dynamics, Analysis and Forecast 2020-2028

The Global Anxiety Disorders and Depression Treatment Market Report recently published by QYReports is a professional and in-depth study on the current state of the Anxiety Disorders and Depression Treatment industry. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques such as graphs, charts, tables as well as pictures. The report is studied with various aspects of the existing industries such as types, size, application, and end-users. It examines the Global Anxiety Disorders and Depression Treatment Market Industries to get better insights for improving the performance of the companies.

Request to Get the PDF Sample of the Report: https://www.qyreports.com/request-sample/?report-id=191351

This report splits Global into several key Region with sales, revenue, market share and growth rate of Global Anxiety Disorders and Depression Treatment Market in regions like North America, Latin America, Asia-Pacific, Europe, and India. The regions have been considered for studies on the basis of productivity, types of products or services along with its features. It also identifies the competitive landscape of Global Anxiety Disorders and Depression Treatment Market industries to understand the competition at domestic as well as global level. Analysts of this report throw light on different attributes such as, recent developments, technological platforms, tools and techniques that help to understand the existing market effectively.

The Global Anxiety Disorders and Depression Treatment Market report gives a detailed description about major pillars of the businesses such as strengths, weaknesses, and challenges in front of the businesses to get a clear idea about ups-downs stages of the businesses. It evaluates various economic facts of the companies such as shares, profit margins and pricing structures to understand the financial terms effectively. Key segmentation and sub-segmentation have been explained in the report to get useful information to make informed decisions in the businesses. Furthermore, it focuses on some significant factors, which are driving or limiting the progress of the businesses.

Major Market Players Profiled in the Global Anxiety Disorders and Depression Treatment Market Report include:

  • Pfizer Inc
  • GlaxoSmithKline
  • Merck Co. Inc
  • AstraZeneca
  • Eli Lily Co
  • Johnson Johnson
  • Forest Laboratories, Inc
  • Sanofi-Aventis
  • Lundbeck A/S
  • Bristol-Myers Squibb Company

Market split by product:

  • Antidepressant Drugs
  • Therapy Devices

Market split by applications:

  • Major Depressive Disorder (MDD)
  • Obsessive-Compulsive Disorder (OCD)
  • Phobia
  • Others

Ask for Discount@ https://www.qyreports.com/ask-for-discount/?report-id=191351

The Global Anxiety Disorders and Depression Treatment Market Report focuses on-demand supply chain to understand the requirement from various global clients along with some significant features. The turning point of the industries has been presented by giving effective approaches to discover global customers massively. SWOT and Porter’s Five model have been used for analyzing the Global Anxiety Disorders and Depression Treatment Market on the basis of strengths, challenges and global opportunities in front of the businesses. This report has been aggregated on the basis of recent scope, challenges in front of the businesses and global opportunities to enlarge the Global Anxiety Disorders and Depression Treatment Market sector in upcoming years.

Market Event Factors Analysis:

Market driver

  • Increasing Anxiety Disorders and Depression Treatment Market invasion of new technologies.
  • For a full detailed, view our report
  • Market challenge
  • Stringent regulatory challenges in Anxiety Disorders and Depression Treatment applications.
  • For a full detailed, view our report
  • Market trend
  • Rising demand for Anxiety Disorders and Depression Treatment in market.
  • For a full detailed, view our report

Enquiry before Buying this premium Report: https://www.qyreports.com/enquiry-before-buying/?report-id=191351

Key questions answered in Global Anxiety Disorders and Depression Treatment Market Report:

  • What will the market size be in 2028 and what will the growth rate be?
  • What are the key market trends?
  • What is key factor driving this market?
  • What are the challenges to market growth?
  • Who are the major key vendors in this market space?
  • What are the market opportunities, market risk and market overview and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

In the end the Global Anxiety Disorders and Depression Treatment Market Report delivers conclusion which includes Research Findings, Market Size Estimation, Market Share, Consumer Needs/Customer Preference Change, Data Source. These factors will increase business overall.

About QYReports:

We at QYReports, a leading market research report publisher cater to more than 4,000 prestigious clients worldwide meeting their customized research requirements in terms of market data size and its application. Our list of customers includes renowned Chinese company’s multinational companies, SME’s and private equity firms. Our business study covers a market size of over 30 industries offering you accurate, in depth and reliable market insight, industry analysis and structure. QYReports specialize in forecasts needed for investing in an and execution of a new project globally and in Chinese markets.

Contact Us:

Name: Jones John

Contact number: +1-510-560-6005

204, Professional Center,

7950 NW 53rd Street, Miami, Florida 33166



Most youngsters are secretly battling with Bulimia Nervosa, eating disorder

New Delhi: The most recent Netflix’s series The Crown, throws light on Princess Diana’s fight with an eating disorder – Bulimia Nervosa, a perilous eating disorder of bingeing and then purging the food. This condition is a rising concern seen among young people today, and numerous such cases are currently being accounted for in India. Eating disorders are common but under-diagnosed conditions and are classified into different types based on the clinical features.

Bulimia nervosa is one of the most prevalent eating disorders and predominantly affects females (up to 2 per cent of females) of which 95 per cent are in the 12-25-year age group, Dr. Pramod Krishnan – Consultant and HOD – Neurology, Manipal Hospitals tells IANSlife. However, the incidence in males is increasing, he points out.

Since Bulimia is a disorder that can go unnoticed among parents, the expert shares the signs to watch out for:

Recurrent episodes of uncontrolled binge eating (consuming an abnormally large portion of food in a short period of time) associated with compensatory behaviours like self-induced vomiting, exercise, fasting, and purging using laxatives.

These episodes should occur at least once a week for a minimum period of 3 months to qualify for a diagnosis of bulimia nervosa. The cause of this condition is unknown and is probably multifactorial involving environmental influences like societal idealisation and emphasis about body shape, anxiety, personality disorders and sometimes, childhood sexual abuse. Genetic factors related to neurotransmitters like serotonin and dopamine may play a role.

Patients often feel they are ‘fat’ and are unduly concerned about their body image, like body weight and shape.

They develop weight fluctuations, swelling of feet, parotid gland enlargement, dental erosions, and calluses on fingers due to episodes of binge eating and induced vomiting.

They often develop complex eating and exercise routines with frequent visits to the bathroom.

Depression, anxiety, personality disorders and obsessive-compulsive disorders are common associated conditions.

Tests for metabolic and hormonal abnormalities are required as these complications may arise from the eating and purging habits. Patients with bulimia nervosa have a higher mortality rate compared to the general population.

The treatment requires a multi-disciplinary approach working in sync with the patient and family, involving:

Psychologists, psychiatrists, physicians, and nutritionists specialising in adolescent medicine

Psychotherapy is the foundation for successful treatment of bulimia nervosa

Cognitive behavioural therapy and interpersonal psychotherapy are proven therapies for bulimia nervosa

Mindfulness practices like meditation and yoga are also helpful

Medications like SSRIs may be useful in patients with psychiatric symptoms or not responding to psychotherapy. About 80 per cent of patients recover with therapy but 20 per cent may relapse and may be challenging to manage.

Deep Transcranial Magnetic Stimulation Benefited Patients With Severe Symptoms of Obsessive Compulsive Disorder

A prospective, double-blind, placebo sham-controlled study by researchers from Baylor College of Medicine found that patients with a higher symptom severity of obsessive compulsive disorder (OCD) were more likely to respond to deep transcranial magnetic stimulation (dTMS). The results were published in the Journal of Psychiatric Research.

Patients (N=100) with primary OCD were recruited at 11 sites between 2014 and 2017 for this study. Patients were randomized to receive 29 dTMS treatments over 6 weeks (5 per week for 5 weeks and 4 during week 6) or a sham treatment. The dTMS had an H shaped coil design which stimulated the dorsal medial prefrontal cortex (mPFC)-anterior cingulate cortex (ACC) bilaterally. The treatment group received 50 trains and 2000 pulses (20 Hz) per session in which the pulse trains were 2 seconds with a 20 second inter-train interval.

Patients were 84% White, 59% men, and aged mean 39 years. OCD symptoms were moderate to severe (57%), moderate (35%), and severe (7%).

At treatment conclusion, the model which incorporated fixed and random effects for dTMS therapy on OCD symptom reduction was significant (c2[2], 136.72; P .001) but was outperformed by a model which included moderators (c2[24], 50.54; P =.001). Significant cofactors associated with more rapid symptom reduction included older age (d, -0.62; P =.005), lower baseline OCD severity (d, 0.50; P =.023), and lower baseline disability (d, 0.47; P =.034).

Continue Reading

The significant moderator was the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS; d, -0.54; P =.017), in which patients in the treatment group reported a 6.3 Y-BOCS reduction and patients in the sham group, a 4.4-point reduction. Among patients who a Y-BOCS score of ³28 points at baseline, they reported a 5.9-point reduction in the treatment cohort and 2.0 point reduction in the sham group.

At 4-weeks post treatment, the fixed and random effects model (c2[2], 156.88; P .001) outperformed the model which included moderators (c2[24], 32.72; P =.11). Only baseline severity remained significant (d, -0.45; P =.042), although older age was trending toward significance (d, -0.43; P =.051).

The baseline Y-BOCS score remained significant at 4 weeks, in which those with a baseline ³28 points (d, -0.67; P =.047) reported a 7.1-point reduction in the treatment arm and 2.9-point reduction in the sham arm.

The major limitation of this study was the lack of diversity among its participants, making it unclear whether these results may be generalizable.

These findings suggested that bilateral dTMS stimulation of the mPFC/ACC may be effective for the treatment of patients with increased symptom severity. Patients with lower OCD severity would likely benefit more from other therapeutics.

Disclosure: Multiple authors declared affiliations with industry. Please refer to the original article for a full list of disclosures.


Storch EA, Tendler A, Schneider SC, Guzick AG, La Buissonniere-Ariza V, Goodman WK. Moderators and predictors of response to deep transcranial magnetic stimulation for obsessive-compulsive disorder. J Psychiatr Res. 2020;S0022-3956(20)31026-8. doi:10.1016/j.jpsychires.2020.10.023